Usefulness of a serological panel test in the assessment of gastritis in symptomatic children

Gian Luigi De Angelis, Lucas Giovanni Cavallaro, Valentina Maffini, Ali Mahamat Moussa, Fabiola Fornaroli, Stefania Liatopoulou, Barbara Bizzarri, Roberta Merli, Giuseppe Comparato, Pietro Caruana, Giulia Martina Cavestro, Angelo Franzé, Francesco Di Mario

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Background: Non-invasive methods are advisable for the detection of Helicobacter pylori-related chronic gastritis in pediatric patients. Serum pepsinogens I and II (sPGII and sPGII), gastrin-17 (G-17) and anti-H. pylori antibodies (IgG-Hp) have been proposed as a 'serological gastric biopsy'. Aim: To assess H. pylori infection and to evaluate gastric mucosa status in a pediatric population by means of serological parameters such as sPGI, sPGII, G-17 and IgG-Hp. Methods: 45 consecutively children evaluated for upper gastrointestinal symptoms were analyzed. All children were submitted to upper gastrointestinal endoscopy with biopsies. Serum samples were analyzed for IgG-Hp, sPGII, sPGI and G-17 (Biohit, Helsinki, Finland). Results: 18 children had H. pylori-related mild or moderate non-atrophic chronic gastritis. They presented significantly higher mean levels of sPGII and of IgG-Hp than negative ones, eitherunder or up to 10 years. sPGI showed significantly increased levels in H. pylori-positive patients only over 10 years. G-17 levels were not different between H. pylori-positive and -negative ones. The best cut-offs of IgG-Hp, sPGII and of product IgG-Hp·sPGII, to identify H. pylori infection, were 30 IU/l, 9 μg/l, and 241 IU/l·μg/l, respectively. The product IgG-Hp·sPGII identified H. pylori infection with a 100% sensitivity, 92% specificity, 90% positive predictive value and 100% negative predictive value. IgG-Hp and IgG-Hp showed a correlation (r = 0.94; p <0.001). Conclusions: Combined analysis of sPGII and IgG-Hp antibody levels could be recommended as a non-invasive panel for the assessment of H. pylori-related histological alterations of gastric mucosa in childhood.

Original languageEnglish
Pages (from-to)206-213
Number of pages8
JournalDigestive Diseases
Volume25
Issue number3
DOIs
Publication statusPublished - Sep 2007

Fingerprint

Serologic Tests
Gastritis
Helicobacter pylori
Immunoglobulin G
Helicobacter Infections
Gastric Mucosa
Pepsinogen C
Pediatrics
Pepsinogen A
Biopsy
Gastrointestinal Endoscopy
Antibodies
Finland
Serum
Stomach
gastrin 17
Sensitivity and Specificity

Keywords

  • Gastrin-17
  • Gastritis
  • Helicobacter pylori
  • IgG anti-H. pylori antibodies
  • Serum pepsinogens I and II

ASJC Scopus subject areas

  • Gastroenterology
  • Medicine(all)

Cite this

De Angelis, G. L., Cavallaro, L. G., Maffini, V., Moussa, A. M., Fornaroli, F., Liatopoulou, S., ... Di Mario, F. (2007). Usefulness of a serological panel test in the assessment of gastritis in symptomatic children. Digestive Diseases, 25(3), 206-213. https://doi.org/10.1159/000103886

Usefulness of a serological panel test in the assessment of gastritis in symptomatic children. / De Angelis, Gian Luigi; Cavallaro, Lucas Giovanni; Maffini, Valentina; Moussa, Ali Mahamat; Fornaroli, Fabiola; Liatopoulou, Stefania; Bizzarri, Barbara; Merli, Roberta; Comparato, Giuseppe; Caruana, Pietro; Cavestro, Giulia Martina; Franzé, Angelo; Di Mario, Francesco.

In: Digestive Diseases, Vol. 25, No. 3, 09.2007, p. 206-213.

Research output: Contribution to journalArticle

De Angelis, GL, Cavallaro, LG, Maffini, V, Moussa, AM, Fornaroli, F, Liatopoulou, S, Bizzarri, B, Merli, R, Comparato, G, Caruana, P, Cavestro, GM, Franzé, A & Di Mario, F 2007, 'Usefulness of a serological panel test in the assessment of gastritis in symptomatic children', Digestive Diseases, vol. 25, no. 3, pp. 206-213. https://doi.org/10.1159/000103886
De Angelis GL, Cavallaro LG, Maffini V, Moussa AM, Fornaroli F, Liatopoulou S et al. Usefulness of a serological panel test in the assessment of gastritis in symptomatic children. Digestive Diseases. 2007 Sep;25(3):206-213. https://doi.org/10.1159/000103886
De Angelis, Gian Luigi ; Cavallaro, Lucas Giovanni ; Maffini, Valentina ; Moussa, Ali Mahamat ; Fornaroli, Fabiola ; Liatopoulou, Stefania ; Bizzarri, Barbara ; Merli, Roberta ; Comparato, Giuseppe ; Caruana, Pietro ; Cavestro, Giulia Martina ; Franzé, Angelo ; Di Mario, Francesco. / Usefulness of a serological panel test in the assessment of gastritis in symptomatic children. In: Digestive Diseases. 2007 ; Vol. 25, No. 3. pp. 206-213.
@article{738228e9d0f94a3f91c634bd83b21761,
title = "Usefulness of a serological panel test in the assessment of gastritis in symptomatic children",
abstract = "Background: Non-invasive methods are advisable for the detection of Helicobacter pylori-related chronic gastritis in pediatric patients. Serum pepsinogens I and II (sPGII and sPGII), gastrin-17 (G-17) and anti-H. pylori antibodies (IgG-Hp) have been proposed as a 'serological gastric biopsy'. Aim: To assess H. pylori infection and to evaluate gastric mucosa status in a pediatric population by means of serological parameters such as sPGI, sPGII, G-17 and IgG-Hp. Methods: 45 consecutively children evaluated for upper gastrointestinal symptoms were analyzed. All children were submitted to upper gastrointestinal endoscopy with biopsies. Serum samples were analyzed for IgG-Hp, sPGII, sPGI and G-17 (Biohit, Helsinki, Finland). Results: 18 children had H. pylori-related mild or moderate non-atrophic chronic gastritis. They presented significantly higher mean levels of sPGII and of IgG-Hp than negative ones, eitherunder or up to 10 years. sPGI showed significantly increased levels in H. pylori-positive patients only over 10 years. G-17 levels were not different between H. pylori-positive and -negative ones. The best cut-offs of IgG-Hp, sPGII and of product IgG-Hp·sPGII, to identify H. pylori infection, were 30 IU/l, 9 μg/l, and 241 IU/l·μg/l, respectively. The product IgG-Hp·sPGII identified H. pylori infection with a 100{\%} sensitivity, 92{\%} specificity, 90{\%} positive predictive value and 100{\%} negative predictive value. IgG-Hp and IgG-Hp showed a correlation (r = 0.94; p <0.001). Conclusions: Combined analysis of sPGII and IgG-Hp antibody levels could be recommended as a non-invasive panel for the assessment of H. pylori-related histological alterations of gastric mucosa in childhood.",
keywords = "Gastrin-17, Gastritis, Helicobacter pylori, IgG anti-H. pylori antibodies, Serum pepsinogens I and II",
author = "{De Angelis}, {Gian Luigi} and Cavallaro, {Lucas Giovanni} and Valentina Maffini and Moussa, {Ali Mahamat} and Fabiola Fornaroli and Stefania Liatopoulou and Barbara Bizzarri and Roberta Merli and Giuseppe Comparato and Pietro Caruana and Cavestro, {Giulia Martina} and Angelo Franz{\'e} and {Di Mario}, Francesco",
year = "2007",
month = "9",
doi = "10.1159/000103886",
language = "English",
volume = "25",
pages = "206--213",
journal = "Digestive Diseases",
issn = "0257-2753",
publisher = "S. Karger AG",
number = "3",

}

TY - JOUR

T1 - Usefulness of a serological panel test in the assessment of gastritis in symptomatic children

AU - De Angelis, Gian Luigi

AU - Cavallaro, Lucas Giovanni

AU - Maffini, Valentina

AU - Moussa, Ali Mahamat

AU - Fornaroli, Fabiola

AU - Liatopoulou, Stefania

AU - Bizzarri, Barbara

AU - Merli, Roberta

AU - Comparato, Giuseppe

AU - Caruana, Pietro

AU - Cavestro, Giulia Martina

AU - Franzé, Angelo

AU - Di Mario, Francesco

PY - 2007/9

Y1 - 2007/9

N2 - Background: Non-invasive methods are advisable for the detection of Helicobacter pylori-related chronic gastritis in pediatric patients. Serum pepsinogens I and II (sPGII and sPGII), gastrin-17 (G-17) and anti-H. pylori antibodies (IgG-Hp) have been proposed as a 'serological gastric biopsy'. Aim: To assess H. pylori infection and to evaluate gastric mucosa status in a pediatric population by means of serological parameters such as sPGI, sPGII, G-17 and IgG-Hp. Methods: 45 consecutively children evaluated for upper gastrointestinal symptoms were analyzed. All children were submitted to upper gastrointestinal endoscopy with biopsies. Serum samples were analyzed for IgG-Hp, sPGII, sPGI and G-17 (Biohit, Helsinki, Finland). Results: 18 children had H. pylori-related mild or moderate non-atrophic chronic gastritis. They presented significantly higher mean levels of sPGII and of IgG-Hp than negative ones, eitherunder or up to 10 years. sPGI showed significantly increased levels in H. pylori-positive patients only over 10 years. G-17 levels were not different between H. pylori-positive and -negative ones. The best cut-offs of IgG-Hp, sPGII and of product IgG-Hp·sPGII, to identify H. pylori infection, were 30 IU/l, 9 μg/l, and 241 IU/l·μg/l, respectively. The product IgG-Hp·sPGII identified H. pylori infection with a 100% sensitivity, 92% specificity, 90% positive predictive value and 100% negative predictive value. IgG-Hp and IgG-Hp showed a correlation (r = 0.94; p <0.001). Conclusions: Combined analysis of sPGII and IgG-Hp antibody levels could be recommended as a non-invasive panel for the assessment of H. pylori-related histological alterations of gastric mucosa in childhood.

AB - Background: Non-invasive methods are advisable for the detection of Helicobacter pylori-related chronic gastritis in pediatric patients. Serum pepsinogens I and II (sPGII and sPGII), gastrin-17 (G-17) and anti-H. pylori antibodies (IgG-Hp) have been proposed as a 'serological gastric biopsy'. Aim: To assess H. pylori infection and to evaluate gastric mucosa status in a pediatric population by means of serological parameters such as sPGI, sPGII, G-17 and IgG-Hp. Methods: 45 consecutively children evaluated for upper gastrointestinal symptoms were analyzed. All children were submitted to upper gastrointestinal endoscopy with biopsies. Serum samples were analyzed for IgG-Hp, sPGII, sPGI and G-17 (Biohit, Helsinki, Finland). Results: 18 children had H. pylori-related mild or moderate non-atrophic chronic gastritis. They presented significantly higher mean levels of sPGII and of IgG-Hp than negative ones, eitherunder or up to 10 years. sPGI showed significantly increased levels in H. pylori-positive patients only over 10 years. G-17 levels were not different between H. pylori-positive and -negative ones. The best cut-offs of IgG-Hp, sPGII and of product IgG-Hp·sPGII, to identify H. pylori infection, were 30 IU/l, 9 μg/l, and 241 IU/l·μg/l, respectively. The product IgG-Hp·sPGII identified H. pylori infection with a 100% sensitivity, 92% specificity, 90% positive predictive value and 100% negative predictive value. IgG-Hp and IgG-Hp showed a correlation (r = 0.94; p <0.001). Conclusions: Combined analysis of sPGII and IgG-Hp antibody levels could be recommended as a non-invasive panel for the assessment of H. pylori-related histological alterations of gastric mucosa in childhood.

KW - Gastrin-17

KW - Gastritis

KW - Helicobacter pylori

KW - IgG anti-H. pylori antibodies

KW - Serum pepsinogens I and II

UR - http://www.scopus.com/inward/record.url?scp=35448987728&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35448987728&partnerID=8YFLogxK

U2 - 10.1159/000103886

DO - 10.1159/000103886

M3 - Article

VL - 25

SP - 206

EP - 213

JO - Digestive Diseases

JF - Digestive Diseases

SN - 0257-2753

IS - 3

ER -